FeesSafety
Pluang+

Myriad Genetics to present at three major healthcare investor conferences in Nov-Dec 2026

Market News
02 Nov 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
Myriad Genetics to present at three major healthcare investor conferences in Nov-Dec 2026

Myriad Genetics, a leader in molecular diagnostics and precision medicine, announced its participation in three upcoming healthcare investor conferences: UBS Global Healthcare Conference on Nov 10, Stephens Investment Conference on Nov 18, and Piper Sandler Healthcare Conference on Dec 2, 2026. The company will hold fireside chats at each event, sharing insights on its molecular testing innovations that aid in disease risk assessment and treatment guidance. These presentations will be accessible via live webcast on Myriad's investor website, providing investors direct access to company updates and strategic outlooks.

Myriad Genetics' participation in upcoming healthcare investor conferences provides context for readers interested in healthcare stocks. For readers following the health sector, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: out of 150 priced US health-sector stocks, 48 rose and 100 fell. Notable movers include Regeneron Pharmaceuticals Inc (REGN) at USD 927.38 with a 1-day change of +13.27%, Ginkgo Bioworks Holdings Inc (DNA) at USD 9.81 down -12.60%, and Twist Bioscience Corp (TWST) at USD 152.02 down -12.36%.

More News

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
1 hour ago
Exosens reports 50.9M shares and 59.1M voting rights as of October 31, 2026

Exosens reports 50.9M shares and 59.1M voting rights as of October 31, 2026

Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...

Company Fundamentals
Neutral
4 hours ago
Exosens reports total shares and voting rights as of October 31, 2026, confirming capital structure details.

Exosens reports total shares and voting rights as of October 31, 2026, confirming capital structure details.

Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...

Company Fundamentals
Neutral
4 hours ago
Centerspace reports Q3 net income jump to $7.28/share amid property sales and merger plans with IRT.

Centerspace reports Q3 net income jump to $7.28/share amid property sales and merger plans with IRT.

Centerspace announced a net income of $7.28 per diluted share for Q3 2026, up from $3.19 in the prior year, driven by gains from selling 14 apartment communities. Despite flat same-store revenues, property expenses rose 4.2%, causing a 2.7% decline i...

Company Fundamentals
Neutral
5 hours ago
XAI Floating Rate Trust declares monthly dividend of $0.225 per share for December 2026.

XAI Floating Rate Trust declares monthly dividend of $0.225 per share for December 2026.

XAI Floating Rate & Alternative Income Trust announced a monthly dividend of $0.225 per common share, payable on December 1, 2026, unchanged from the previous month. The dividend will be paid to shareholders of record as of November 16, 2026. Distrib...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App